There are 2789 resources available
1706P - A comparative assessment of neutropenia events, healthcare resource use, and costs among patients treated with long-acting granulocyte-colony stimulating factor in Germany
Presenter: Hartmut Link
Session: ePoster Display
1707P - A single G-CSF administration is enough to limit neutropenia in patients treated by eribulin
Presenter: Antonin Schmitt
Session: ePoster Display
1708P - Severe neutropenia (grade 4, Gr4N) as a population-based predictor for adverse clinical outcome of chemotherapy induced neutropenia (CIN)
Presenter: Ramon Mohanlal
Session: ePoster Display
1611P - Health-related quality of life, vaccine uptake and immune response among cancer patients undergoing treatment during the COVID-19 pandemic
Presenter: Jane Figueiredo
Session: ePoster Display
1612P - The impact of COVID-19 pandemic on distress level in cancer patients, a cross-sectional multicentric study
Presenter: Anuska Budisavljevic
Session: ePoster Display
1613P - What are the barriers to routine clinical use of teleconsultation in oncology? A retrospective study on patient’s and their physician’s satisfaction with 603 video teleconsultations
Presenter: Thibaut Mottet
Session: ePoster Display
1713P - Accelerometer measured physical activity (PA) and biomarkers in breast cancer (BC) survivors
Presenter: Maria Romero-Elias
Session: ePoster Display
1616P - Drop in early-stage colorectal cancer diagnoses after COVID-19: Preliminary report from the COVID-DELAY study
Presenter: Giulia Mentrasti
Session: ePoster Display
1715P - Rapid drug desensitization (RDD) to anticancer drugs: A 4-year monocentric experience
Presenter: Giulia Piacentini
Session: ePoster Display
1618P - Worsening of breast and cervical cancer stage at diagnosis due to COVID-19 pandemic
Presenter: Ana Paula Messias
Session: ePoster Display